Related references
Note: Only part of the references are listed.Current Concepts in Multiple Sclerosis: Autoimmunity Versus Oligodendrogliopathy
Jin Nakahara et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2012)
Radical changes in multiple sclerosis pathogenesis
Jack van Horssen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
The molecular basis of nutritional intervention in multiple sclerosis: A narrative review
P. Riccio
COMPLEMENTARY THERAPIES IN MEDICINE (2011)
Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients
George P. Christophi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity
Nicolas G. Bazan et al.
MOLECULAR NEUROBIOLOGY (2011)
The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment
Sabine Lindquist et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis
Lynne Shinto et al.
AUTOIMMUNE DISEASES (2011)
Nutrition, geoepidemiology, and autoimmunity
Carlo Selmi et al.
AUTOIMMUNITY REVIEWS (2010)
Questionnaires in clinical trials: guidelines for optimal design and administration
Phil Edwards
TRIALS (2010)
Antioxidant therapy in multiple sclerosis
Abbas Mirshafiey et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis
Lahar R. Mehta et al.
NATURE CLINICAL PRACTICE NEUROLOGY (2009)
Eicosapentaenonic add stimulates the expression of myelin proteins in rat brain
Serafina Salvati et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis
Laurence S. Harbige et al.
BRITISH JOURNAL OF NUTRITION (2007)
Modulation of inflammation in brain: a matter of fat
Akhlaq A. Farooqui et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis
CN Serhan et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2004)
Review of MS patient survival on a swank low saturated fat diet
RL Swank et al.
NUTRITION (2003)
Peroxisome proliferator-activated receptor-γ agonists prevent experimental autoimmune encephalomyelitis
DL Feinstein et al.
ANNALS OF NEUROLOGY (2002)
Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production
MA Harris et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2001)
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease
L Probert et al.
BRAIN (2000)
Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients
I Nordvik et al.
ACTA NEUROLOGICA SCANDINAVICA (2000)
Share Paper
